Variant report
Variant | rs13006598 |
---|---|
Chromosome Location | chr2:74010592-74010593 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:13)
- CpG islands (count:61)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:13 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | FOSL2 | chr2:74010378-74010865 | A549 | lung: | n/a | chr2:74010778-74010789 |
2 | HEY1 | chr2:74010441-74010908 | HepG2 | liver: | n/a | n/a |
3 | USF1 | chr2:74010528-74010763 | H1-hESC | embryonic stem cell: | n/a | chr2:74010683-74010694 |
4 | USF1 | chr2:74010544-74010750 | HepG2 | liver: | n/a | chr2:74010683-74010694 |
5 | POLR2A | chr2:74010460-74010764 | HCT-116 | colon: | n/a | n/a |
6 | JUND | chr2:74010575-74010877 | HepG2 | liver: | n/a | chr2:74010779-74010790 |
7 | FOSL2 | chr2:74010457-74011032 | HepG2 | liver: | n/a | chr2:74010778-74010789 |
8 | USF1 | chr2:74010542-74010781 | HepG2 | liver: | n/a | chr2:74010683-74010694 |
9 | FOSL2 | chr2:74010094-74010934 | HepG2 | liver: | n/a | chr2:74010778-74010789 |
10 | MAX | chr2:74010528-74010863 | A549 | lung: | n/a | n/a |
11 | POLR2A | chr2:74010516-74010855 | HCT-116 | colon: | n/a | n/a |
12 | JUND | chr2:74010496-74010969 | HepG2 | liver: | n/a | chr2:74010779-74010790 |
13 | MAX | chr2:74010379-74010877 | A549 | lung: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:74010554-74010604 | AG04450 | lung: | fetal |
2 | chr2:74010554-74010604 | AG09309 | skin: | n/a |
3 | chr2:74010554-74010604 | AG09319 | gingival: | n/a |
4 | chr2:74010554-74010604 | CMK | blood: | n/a |
5 | chr2:74010554-74010604 | NT2-D1 | testis: | n/a |
6 | chr2:74010554-74010604 | GM12891 | blood: | n/a |
7 | chr2:74010554-74010604 | SK-N-SH | brain: | n/a |
8 | chr2:74010554-74010604 | GM12878 | blood: | n/a |
9 | chr2:74010554-74010604 | NHBE | bronchial: | n/a |
10 | chr2:74010554-74010604 | HepG2 | liver: | n/a |
11 | chr2:74010554-74010604 | SK-N-SH_RA | brain: | n/a |
12 | chr2:74010554-74010604 | HCM | heart: | n/a |
13 | chr2:74010554-74010604 | GM06990 | blood: | n/a |
14 | chr2:74010554-74010604 | H1-hESC | embryonic stem cell: | embryo |
15 | chr2:74010554-74010604 | HL-60 | blood: | n/a |
16 | chr2:74010554-74010604 | AG10803 | skin: | n/a |
17 | chr2:74010554-74010604 | HMEC | breast: | n/a |
18 | chr2:74010554-74010604 | HRCEpiC | kidney: | n/a |
19 | chr2:74010554-74010604 | HIPEpiC | eye: | n/a |
20 | chr2:74010554-74010604 | AoSMC | blood vessel: | n/a |
21 | chr2:74010554-74010604 | HUVEC | blood vessel: | n/a |
22 | chr2:74010554-74010604 | BJ | skin: | n/a |
23 | chr2:74010554-74010604 | NH-A | brain: | n/a |
24 | chr2:74010554-74010604 | K562 | blood: | n/a |
25 | chr2:74010554-74010604 | AG04449 | skin: | fetal |
26 | chr2:74010554-74010604 | SKMC | muscle: | n/a |
27 | chr2:74010554-74010604 | Caco-2 | colon: | n/a |
28 | chr2:74010554-74010604 | U87 | brain: | n/a |
29 | chr2:74010554-74010604 | BE2_C | brain: | n/a |
30 | chr2:74010554-74010604 | RPTEC | kidney: | n/a |
31 | chr2:74010554-74010604 | HRE | kidney: | n/a |
32 | chr2:74010554-74010604 | NB4 | blood: | n/a |
33 | chr2:74010554-74010604 | HCPEpiC | choroid plexus: | n/a |
34 | chr2:74010554-74010604 | MCF-7 | breast: | n/a |
35 | chr2:74010554-74010604 | HNPCEpiC | eye: | n/a |
36 | chr2:74010554-74010604 | Hepatocyte | liver: | n/a |
37 | chr2:74010554-74010604 | HAEpiC | amniotic membrane: | n/a |
38 | chr2:74010554-74010604 | SK-N-MC | brain: | n/a |
39 | chr2:74010554-74010604 | GM19239 | blood: | n/a |
40 | chr2:74010554-74010604 | IMR90 | lung: | fetal |
41 | chr2:74010554-74010604 | PANC-1 | pancreas: | n/a |
42 | chr2:74010554-74010604 | SAEC | small airway: | n/a |
43 | chr2:74010554-74010604 | ECC-1 | luminal epithelium: | n/a |
44 | chr2:74010554-74010604 | T-47D | breast: | n/a |
45 | chr2:74010554-74010604 | Hela-S3 | cervix: | n/a |
46 | chr2:74010554-74010604 | ProgFib | skin: | n/a |
47 | chr2:74010554-74010604 | HRPEpiC | eye: | n/a |
48 | chr2:74010554-74010604 | Jurkat | blood: | n/a |
49 | chr2:74010554-74010604 | A549 | lung: | n/a |
50 | chr2:74010554-74010604 | LNCaP | prostate: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
DUSP11 | TF binding region |
C2orf78 | TF binding region |
C2orf78 | CpG island |
DUSP11 | CpG island |
rs_ID | r2[population] |
---|---|
rs10172044 | 0.96[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs10191988 | 0.91[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs10193032 | 0.98[ASN][1000 genomes] |
rs10203740 | 0.81[AMR][1000 genomes];0.92[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs10208995 | 0.86[AMR][1000 genomes];0.95[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs11126415 | 0.87[EUR][1000 genomes] |
rs11126416 | 0.95[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs11126417 | 0.93[EUR][1000 genomes] |
rs11891140 | 0.82[AMR][1000 genomes];0.91[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs11892172 | 0.84[AMR][1000 genomes];0.98[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs11894953 | 0.92[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs12052539 | 0.87[EUR][1000 genomes] |
rs12053242 | 0.87[EUR][1000 genomes] |
rs12233112 | 0.87[AMR][1000 genomes] |
rs12615807 | 0.82[AMR][1000 genomes];0.91[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs12619258 | 0.85[AMR][1000 genomes] |
rs12624267 | 0.83[AMR][1000 genomes];0.96[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs12713789 | 0.83[AMR][1000 genomes];0.91[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs12713790 | 0.83[AMR][1000 genomes];0.91[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs12713791 | 0.83[AMR][1000 genomes];0.91[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs12713793 | 0.88[AMR][1000 genomes];0.91[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs12713794 | 0.87[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs12713795 | 0.86[AMR][1000 genomes];0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs12713797 | 0.95[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs12713798 | 0.89[AMR][1000 genomes];0.96[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs12992607 | 0.84[AFR][1000 genomes];0.93[AMR][1000 genomes];0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs12997568 | 0.80[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs13003035 | 0.84[AFR][1000 genomes];0.94[AMR][1000 genomes];0.91[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs13005729 | 0.84[AMR][1000 genomes] |
rs13006448 | 0.84[AMR][1000 genomes] |
rs13013228 | 0.84[AMR][1000 genomes] |
rs13014700 | 0.83[AMR][1000 genomes] |
rs13015885 | 0.83[AMR][1000 genomes] |
rs13020517 | 0.84[AMR][1000 genomes];0.86[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs13031853 | 0.84[AMR][1000 genomes] |
rs13031866 | 0.85[AMR][1000 genomes] |
rs13033744 | 0.84[AMR][1000 genomes];0.95[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs13383097 | 0.83[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs17350056 | 0.86[AMR][1000 genomes] |
rs17350125 | 0.84[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs17350188 | 0.90[AMR][1000 genomes];0.92[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs17434655 | 0.81[AMR][1000 genomes] |
rs1806683 | 0.87[EUR][1000 genomes] |
rs1815028 | 0.84[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs2001436 | 0.81[AMR][1000 genomes] |
rs2001490 | 0.81[AMR][1000 genomes] |
rs2006997 | 0.91[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs2012574 | 0.85[AMR][1000 genomes] |
rs2116367 | 0.83[AMR][1000 genomes];0.99[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs2272051 | 0.87[AMR][1000 genomes];0.99[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs2272178 | 0.90[AMR][1000 genomes];0.95[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs2421557 | 0.84[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs2421558 | 0.81[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs2421559 | 0.91[AMR][1000 genomes];0.99[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs2421575 | 0.83[AMR][1000 genomes] |
rs2421672 | 0.87[AMR][1000 genomes];0.91[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs2421674 | 0.88[AMR][1000 genomes];0.91[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs2421675 | 0.84[AMR][1000 genomes];0.91[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs2421676 | 0.93[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs2421677 | 0.89[EUR][1000 genomes] |
rs2462127 | 0.90[AFR][1000 genomes];0.87[AMR][1000 genomes];0.92[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs35498419 | 0.82[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs35767294 | 0.84[AMR][1000 genomes] |
rs35791379 | 0.89[AMR][1000 genomes];0.96[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs3813228 | 0.86[AMR][1000 genomes];0.99[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs3980695 | 0.84[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs4241257 | 0.87[EUR][1000 genomes] |
rs4358149 | 0.83[AMR][1000 genomes];0.91[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs4513320 | 0.82[AMR][1000 genomes] |
rs4852316 | 0.85[EUR][1000 genomes] |
rs4852975 | 0.87[AMR][1000 genomes] |
rs4852976 | 0.81[AFR][1000 genomes];0.88[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs4852977 | 0.87[EUR][1000 genomes] |
rs4852978 | 0.82[AMR][1000 genomes];0.90[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs6748233 | 0.83[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs6749841 | 0.86[AMR][1000 genomes];0.91[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs6750494 | 0.83[AMR][1000 genomes];0.90[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs6750515 | 0.83[AMR][1000 genomes];0.90[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs6750877 | 0.86[AMR][1000 genomes];0.86[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs6755500 | 0.85[AMR][1000 genomes];0.90[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs7210 | 0.88[AMR][1000 genomes];0.91[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs732778 | 0.85[AMR][1000 genomes];0.92[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs7368570 | 0.81[AMR][1000 genomes] |
rs7558546 | 0.87[EUR][1000 genomes] |
rs7591112 | 0.82[AMR][1000 genomes];0.91[EUR][1000 genomes] |
rs7597302 | 0.87[AMR][1000 genomes];0.97[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs7599453 | 0.83[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs891695 | 0.82[AMR][1000 genomes];0.94[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs891696 | 0.96[AFR][1000 genomes];0.92[AMR][1000 genomes];0.89[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs9309475 | 0.89[AMR][1000 genomes];0.94[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs9309476 | 0.84[AMR][1000 genomes];0.94[EUR][1000 genomes];0.94[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv428051 | chr2:73717032-74030067 | ZNF genes & repeats Strong transcription Weak transcription Active TSS Enhancers Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 22 gene(s) | inside rSNPs | diseases |
2 | esv2757806 | chr2:73717032-74078592 | Active TSS Weak transcription ZNF genes & repeats Enhancers Genic enhancers Flanking Active TSS Strong transcription Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 36 gene(s) | inside rSNPs | diseases |
3 | esv2759060 | chr2:73717032-74078592 | Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Strong transcription Genic enhancers Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 36 gene(s) | inside rSNPs | diseases |
4 | nsv1013385 | chr2:73822056-74041441 | Strong transcription Flanking Active TSS Enhancers Weak transcription Genic enhancers Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 20 gene(s) | inside rSNPs | diseases |
5 | nsv834260 | chr2:73906106-74076520 | Weak transcription Enhancers Active TSS Flanking Active TSS Strong transcription Genic enhancers ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
6 | nsv1000675 | chr2:73919185-74038946 | Active TSS Strong transcription Weak transcription Enhancers Genic enhancers Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 19 gene(s) | inside rSNPs | diseases |
7 | nsv2780 | chr2:73994168-74057248 | Enhancers Active TSS Strong transcription Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 25 gene(s) | inside rSNPs | diseases |
8 | esv1828210 | chr2:74005068-74038451 | Enhancers Flanking Active TSS Weak transcription Active TSS Strong transcription Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 11 gene(s) | inside rSNPs | diseases |
9 | esv1798760 | chr2:74008555-74037432 | Enhancers Flanking Active TSS Weak transcription Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 2 gene(s) | inside rSNPs | diseases |
10 | esv1796755 | chr2:74008755-74037232 | Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 2 gene(s) | inside rSNPs | diseases |
11 | esv1829180 | chr2:74008755-74040242 | Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 3 gene(s) | inside rSNPs | diseases |
12 | nsv10024 | chr2:74009680-74037260 | Weak transcription Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandlncRNA | 2 gene(s) | inside rSNPs | diseases |
13 | esv12664 | chr2:74009707-74039385 | Active TSS Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 3 gene(s) | inside rSNPs | diseases |
14 | nsv471530 | chr2:74009713-74037182 | Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandlncRNA | 2 gene(s) | inside rSNPs | diseases |
15 | nsv963622 | chr2:74009937-74011888 | Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh | TF binding regionCpG island | 2 gene(s) | inside rSNPs | diseases |
16 | esv3371250 | chr2:74010144-74014742 | Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG island | 2 gene(s) | inside rSNPs | diseases |
17 | esv1794852 | chr2:74010258-74036308 | Weak transcription Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS | TF binding regionCpG islandlncRNA | 2 gene(s) | inside rSNPs | diseases |
18 | esv1831787 | chr2:74010258-74036308 | Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent/Poised TSS | TF binding regionCpG islandlncRNA | 2 gene(s) | inside rSNPs | diseases |
19 | esv1795724 | chr2:74010341-74036605 | Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS | TF binding regionCpG islandlncRNA | 2 gene(s) | inside rSNPs | diseases |
20 | esv1830089 | chr2:74010341-74036605 | Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandlncRNA | 2 gene(s) | inside rSNPs | diseases |
21 | esv1830247 | chr2:74010341-74036605 | Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS | TF binding regionCpG islandlncRNA | 2 gene(s) | inside rSNPs | diseases |
22 | esv1803581 | chr2:74010541-74038731 | Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 2 gene(s) | inside rSNPs | diseases |
23 | esv1825297 | chr2:74010541-74040242 | Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 3 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:74010000-74010600 | Enhancers | NHEK | skin |
2 | chr2:74010000-74010800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr2:74010000-74010800 | Enhancers | Hela-S3 | cervix |
4 | chr2:74010000-74011000 | Enhancers | HMEC | breast |
5 | chr2:74010200-74010600 | Flanking Active TSS | ES-I3 Cell Line | embryonic stem cell |
6 | chr2:74010200-74010800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
7 | chr2:74010400-74010600 | Flanking Active TSS | A549 | lung |
8 | chr2:74010400-74010600 | Bivalent/Poised TSS | HepG2 | liver |
9 | chr2:74010400-74010800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |